These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16164748)

  • 21. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
    Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
    Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum.
    Zakeri S; Afsharpad M; Kazemzadeh T; Mehdizadeh K; Shabani A; Djadid ND
    Am J Trop Med Hyg; 2008 Apr; 78(4):633-40. PubMed ID: 18385361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
    Dokomajilar C; Lankoande ZM; Dorsey G; Zongo I; Ouedraogo JB; Rosenthal PJ
    Am J Trop Med Hyg; 2006 Jul; 75(1):162-5. PubMed ID: 16837725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China.
    Zhang GQ; Guan YY; Zheng B; Wu S; Tang LH
    Trop Med Int Health; 2009 Oct; 14(10):1266-71. PubMed ID: 19772548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Plasmodium falciparum chloroquine resistance transporter variant T76 with age-related plasma chloroquine levels.
    May J; Meyer CG
    Am J Trop Med Hyg; 2003 Feb; 68(2):143-6. PubMed ID: 12641402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ; Basco LK; Mazabraud A
    Sante; 2002; 12(4):363-7. PubMed ID: 12626289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
    Talisuna AO; Nalunkuma-Kazibwe A; Langi P; Mutabingwa TK; Watkins WW; Van Marck E; Egwang TG; D'Alessandro U
    Infect Genet Evol; 2004 Dec; 4(4):321-7. PubMed ID: 15374529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The T76 mutation in the pfcrt gene of Plasmodium falciparum and clinical chloroquine resistance phenotypes in Papua, Indonesia.
    Maguire JD; Susanti AI; Krisin ; Sismadi P; Fryauff DJ; Baird JK
    Ann Trop Med Parasitol; 2001 Sep; 95(6):559-72. PubMed ID: 11672462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
    Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique.
    Mayor AG; Gómez-Olivé X; Aponte JJ; Casimiro S; Mabunda S; Dgedge M; Barreto A; Alonso PL
    J Infect Dis; 2001 May; 183(9):1413-6. PubMed ID: 11294676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Bolaji OM; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Am J Trop Med Hyg; 2006 Jul; 75(1):155-61. PubMed ID: 16837724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of molecular markers in Plasmodium falciparum crt and mdr1 with in vitro chloroquine resistance: a Philippine study.
    Hatabu T; Iwagami M; Kawazu S; Taguchi N; Escueta AD; Villacorte EA; Rivera PT; Kano S
    Parasitol Int; 2009 Jun; 58(2):166-70. PubMed ID: 19567229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use.
    Noranate N; Durand R; Tall A; Marrama L; Spiegel A; Sokhna C; Pradines B; Cojean S; Guillotte M; Bischoff E; Ekala MT; Bouchier C; Fandeur T; Ariey F; Patarapotikul J; Le Bras J; Trape JF; Rogier C; Mercereau-Puijalon O
    PLoS One; 2007 Jan; 2(1):e139. PubMed ID: 17206274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic evidence for Plasmodium falciparum resistance to chloroquine and pyrimethamine in Indochina and the Western Pacific between 1984 and 1998.
    Saito-Nakano Y; Tanabe K; Kamei K; Iwagami M; Komaki-Yasuda K; Kawazu S; Kano S; Ohmae H; Endo T
    Am J Trop Med Hyg; 2008 Oct; 79(4):613-9. PubMed ID: 18840753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.
    Francis D; Nsobya SL; Talisuna A; Yeka A; Kamya MR; Machekano R; Dokomajilar C; Rosenthal PJ; Dorsey G
    J Infect Dis; 2006 Apr; 193(7):978-86. PubMed ID: 16518760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.
    Mockenhaupt FP; Bedu-Addo G; Eggelte TA; Hommerich L; Holmberg V; von Oertzen C; Bienzle U
    J Infect Dis; 2008 Nov; 198(10):1545-9. PubMed ID: 18834303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chloroquine blood concentrations and molecular markers of chloroquine-resistant Plasmodium falciparum in febrile children in northern Ghana.
    Ehrhardt S; Mockenhaupt FP; Eggelte TA; Agana-Nsiire P; Stollberg K; Anemana SD; Otchwemah RN; Bienzle U
    Trans R Soc Trop Med Hyg; 2003; 97(6):697-701. PubMed ID: 16117966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.